Structure-activity relationship study of prion inhibition by 2-aminopyridine-3,5-dicarbonitrile-based compounds: Parallel synthesis, bioactivity, and in vitro pharmacokinetics

被引:114
作者
May, Barnaby C. H. [1 ]
Zorn, Julie A.
Witkop, Juanita
Sherrill, John
Wallace, Andrew C.
Legname, Giuseppe
Prusiner, Stanley B.
Cohen, Fred E.
机构
[1] Univ Calif San Francisco, Inst Neurodegenerat Dis, San Francisco, CA USA
[2] Univ Calif San Francisco, Dept Neurol Cellular & Mol Pharmacol, San Francisco, CA USA
[3] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA USA
关键词
D O I
10.1021/jm061045z
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
2-Aminopyridine-3,5-dicarbonitrile compounds were previously identified as mimetics of dominant-negative prion protein mutants and inhibit prion replication in cultured cells. Here, we report findings from a comprehensive structure-activity relationship study of the 6-aminopyridine-3,5-dicarbonitrile scaffold. We identify compounds with significantly improved bioactivity (approximately 40-fold) against replication of the infectious prion isoform (PrPSc) and suitable pharmacokinetic profiles to warrant evaluation in animal models of prion disease.
引用
收藏
页码:65 / 73
页数:9
相关论文
共 35 条
[1]   Chirality codes and molecular structure [J].
Aires-De-Sousa, J ;
Gasteiger, J ;
Gutman, I ;
Vidovic, DI .
JOURNAL OF CHEMICAL INFORMATION AND COMPUTER SCIENCES, 2004, 44 (03) :831-836
[2]   New, non-adenosine, high-potency agonists for the human adenosine A2B receptor with an improved selectivity profile compared to the reference agonist n-ethylcarboxamidoadenosine [J].
Beukers, MW ;
Chang, LCW ;
Künzel, JKVD ;
Mulder-Krieger, T ;
Spanjersberg, RF ;
Brussee, J ;
Ijzerman, AP .
JOURNAL OF MEDICINAL CHEMISTRY, 2004, 47 (15) :3707-3709
[3]   Assessing the performance of OMEGA with respect to retrieving bioactive conformations [J].
Boström, J ;
Greenwood, JR ;
Gottfries, J .
JOURNAL OF MOLECULAR GRAPHICS & MODELLING, 2003, 21 (05) :449-462
[4]   SCRAPIE-INFECTED MURINE NEURO-BLASTOMA CELLS PRODUCE PROTEASE-RESISTANT PRION PROTEINS [J].
BUTLER, DA ;
SCOTT, MRD ;
BOCKMAN, JM ;
BORCHELT, DR ;
TARABOULOS, A ;
HSIAO, KK ;
KINGSBURY, DT ;
PRUSINER, SB .
JOURNAL OF VIROLOGY, 1988, 62 (05) :1558-1564
[5]   A series of ligands displaying a remarkable agonistic-antagonistic profile at the adenosine A1 receptor [J].
Chang, LCW ;
Künzel, JKVF ;
Mulder-Krieger, T ;
Spanjersberg, RF ;
Roerink, SF ;
van den Hout, G ;
Beukers, MW ;
Brussee, J ;
IJzerman, AP .
JOURNAL OF MEDICINAL CHEMISTRY, 2005, 48 (06) :2045-2053
[6]  
DeArmond SJ, 1996, CURR TOP MICROBIOL, V207, P125
[7]  
Dyachenko V.D., 1998, RUSS J ORG CHEM+, V34, P557
[8]   STRUCTURE-ACTIVITY-RELATIONSHIPS OF N-6-BENZYLADENOSINE-5'-URONAMIDES AS A(3)-SELECTIVE ADENOSINE AGONISTS [J].
GALLORODRIGUEZ, C ;
JI, XD ;
MELMAN, N ;
SIEGMAN, BD ;
SANDERS, LH ;
ORLINA, J ;
FISCHER, B ;
PU, QL ;
OLAH, ME ;
VANGALEN, PJM ;
STILES, GL ;
JACOBSON, KA .
JOURNAL OF MEDICINAL CHEMISTRY, 1994, 37 (05) :636-646
[9]   TYRPHOSTINS .2. HETEROCYCLIC AND ALPHA-SUBSTITUTED BENZYLIDENEMALONONITRILE TYRPHOSTINS AS POTENT INHIBITORS OF EGF RECEPTOR AND ERBB2/NEU TYROSINE KINASES [J].
GAZIT, A ;
OSHEROV, N ;
POSNER, I ;
YAISH, P ;
PORADOSU, E ;
GILON, C ;
LEVITZKI, A .
JOURNAL OF MEDICINAL CHEMISTRY, 1991, 34 (06) :1896-1907
[10]   Evidence for assembly of prions with left-handed β3-helices into trimers [J].
Govaerts, C ;
Wille, H ;
Prusiner, SB ;
Cohen, FE .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (22) :8342-8347